|
|
 |
|
Viewing report
|
|
|
|
Competitor Analysis: Cardiovascular Peptides
La Merie Publishing, Dec 2011, Pages: 45
PRODUCT DESCRIPTION
The present Competitive Intelligence Report about Cardiovascular Peptides used to treat or prevent heart failure, myocardial infarction, thrombosis, arrhythmias, hypertension, peripheral and cerebral vascular diseases, and hematologic disorders provides a competitor evaluation in the field of R&D projects with cardiovascular peptides as of December 2011.
Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.
The report includes a compilation of current active projects in research and development of cardiovasuclar peptides. In addition, the report lists company-specific R&D pipelines of cardiovascular peptides.
Competitor projects are listed in a tabular format providing information on:
- Drug Codes
- Target / Mechanism of Action
- Class of Compound
- Company
- Product category
- Indication
- R&D Stage
- additional comments with a hyperlink leading to the source of information
ABOUT COMPETITOR ANALYSIS SERIES
The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
